PLASMA-CONCENTRATIONS OF BETAMETHASONE AFTER TOPICAL APPLICATION OF BETAMETHASONE 17-VALERATE - COMPARISON WITH ORAL-ADMINISTRATION

被引:11
|
作者
KUBOTA, K
LO, ES
HUTTINOT, G
ANDERSEN, PH
MAIBACH, HI
机构
[1] UNIV CALIF SAN FRANCISCO,DEPT DERMATOL,SURGE 110,BOX 0989,SAN FRANCISCO,CA 94143
[2] NEW YORK STATE PSYCHIAT INST & HOSP,ANALYT PSYCHOPHARMACOL LABS,NEW YORK,NY 10032
关键词
CORTICOSTEROID; BETAMETHASONE; 17-VALERATE; PERCUTANEOUS ABSORPTION; PHARMACOKINETICS;
D O I
10.1111/j.1365-2125.1994.tb04246.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Plasma concentrations of betamethasone were measured by r.i.a. after oral administration of 0.6 mg betamethasone and topical application of betamethasone 17-valerate in the same five healthy subjects. Betamethasone 17-valerate was prepared as a suspension in medical grade pressure sensitive adhesive and applied to a 100 cm2 area on the back for 28 h. Mean maximum plasma concentrations were 5.0 and 0.24 ng ml-1 and mean AUC values were 75.4 and 7.74 ng ml-1 h after oral and topical administrations, respectively. The mean plasma elimination half-life of betamethasone after the removal of topical betamethasone 17-valerate was 16.6 h which was twice that after oral administration, 8.1 h. Betamethasone 17-valerate may require application to the skin more than twice daily.
引用
收藏
页码:86 / 88
页数:3
相关论文
共 50 条
  • [1] BETAMETHASONE 17-VALERATE - NEW TOPICAL CORTICOSTEROID
    WILLIAMS, DI
    CHURCH, R
    MCKENNA, WB
    WILKINSON, DS
    MILNE, JA
    OVERTON, J
    LYELL, A
    LANCET, 1964, 1 (734): : 1177 - +
  • [2] BETAMETHASONE 17-VALERATE - A CUSTOM-MADE TOPICAL CORTICOSTEROID
    ZIMMERMA.EH
    ARCHIVES OF DERMATOLOGY, 1967, 95 (05) : 514 - +
  • [3] Pharmacodynamics and dermatopharmacokinetics of betamethasone 17-valerate: assessment of topical bioavailability
    Wiedersberg, S.
    Naik, A.
    Leopold, C. S.
    Guy, R. H.
    BRITISH JOURNAL OF DERMATOLOGY, 2009, 160 (03) : 676 - 686
  • [4] ORAL BETAMETHASONE 17-VALERATE IN CHRONIC ULCERATIVE COLITIS AND CROHNS DISEASE
    GILL, AM
    OTAKI, AT
    DALY, JR
    SPENCERP.J
    BRITISH MEDICAL JOURNAL, 1965, 2 (5452): : 29 - &
  • [5] COMPARISON OF BETAMETHASONE 17-VALERATE OINTMENT WITH FLUOCORTOLONE AND FLUOCORTOLONE CAPROATE OINTMENT
    MUNRO, DD
    WILSON, HTH
    RHODES, EL
    BRITISH MEDICAL JOURNAL, 1967, 4 (5574): : 275 - &
  • [6] Compatibility of betamethasone 17-valerate and ketoconazole foam formulations in combination topical therapy
    Tanojo, H
    Lenn, J
    Huang, X
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P173 - P173
  • [7] RELEASE OF BETAMETHASONE 17-VALERATE FROM EXTEMPORANEOUS DILUTIONS OF A PROPRIETARY TOPICAL CREAM
    MAGNUS, AD
    HAIGH, JM
    KANFER, I
    DERMATOLOGICA, 1981, 163 (04): : 331 - 337
  • [8] Palm Olein Emulsion: a Novel Vehicle for Topical Drug Delivery of Betamethasone 17-Valerate
    Ahmad, Kausar
    Win, Thazin
    Jaffri, Juliana Md
    Edueng, Khadijah
    Taher, Muhammad
    AAPS PHARMSCITECH, 2018, 19 (01): : 371 - 383
  • [9] Palm Olein Emulsion: a Novel Vehicle for Topical Drug Delivery of Betamethasone 17-Valerate
    Kausar Ahmad
    Thazin Win
    Juliana Md Jaffri
    Khadijah Edueng
    Muhammad Taher
    AAPS PharmSciTech, 2018, 19 : 371 - 383
  • [10] OBSERVATIONS ON ABSORPTION OF ORAL BETAMETHASONE 17-VALERATE AND ITS THERAPEUTIC VALUE IN ULCERATIVE COLITIS
    FRIEDMAN, M
    FLETCHER, J
    HINTON, JM
    LENNARDJ.JE
    MISIEWICZ, JJ
    PARRISH, JA
    BMJ-BRITISH MEDICAL JOURNAL, 1967, 1 (5536): : 335 - +